Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1952 1
1956 1
1959 3
1960 1
1961 1
1962 1
1965 2
1967 1
1968 2
1969 1
1970 2
1971 1
1973 1
1976 3
1977 1
1978 4
1980 4
1981 11
1982 8
1983 6
1984 7
1985 6
1986 8
1987 18
1988 11
1989 11
1990 13
1991 9
1992 25
1993 10
1994 17
1995 15
1996 20
1997 27
1998 25
1999 34
2000 36
2001 32
2002 31
2003 35
2004 34
2005 29
2006 23
2007 28
2008 36
2009 32
2010 38
2011 42
2012 36
2013 23
2014 33
2015 38
2016 42
2017 42
2018 37
2019 36
2020 74
2021 75
Text availability
Article attribute
Article type
Publication date

Search Results

1,062 results
Results by year
Filters applied: . Clear all
Page 1
Long-term consequences of COVID-19: research needs.
Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, Guaraldi G, Mussini C, Gudiol C, Pujol M, Bandera A, Scudeller L, Paul M, Kaiser L, Leibovici L. Yelin D, et al. Among authors: kaiser l. Lancet Infect Dis. 2020 Oct;20(10):1115-1117. doi: 10.1016/S1473-3099(20)30701-5. Epub 2020 Sep 1. Lancet Infect Dis. 2020. PMID: 32888409 Free PMC article. No abstract available.
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial.
von Dach E, Albrich WC, Brunel AS, Prendki V, Cuvelier C, Flury D, Gayet-Ageron A, Huttner B, Kohler P, Lemmenmeier E, McCallin S, Rossel A, Harbarth S, Kaiser L, Bochud PY, Huttner A. von Dach E, et al. Among authors: kaiser l. JAMA. 2020 Jun 2;323(21):2160-2169. doi: 10.1001/jama.2020.6348. JAMA. 2020. PMID: 32484534 Free PMC article. Clinical Trial.
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
Stringhini S, Wisniak A, Piumatti G, Azman AS, Lauer SA, Baysson H, De Ridder D, Petrovic D, Schrempft S, Marcus K, Yerly S, Arm Vernez I, Keiser O, Hurst S, Posfay-Barbe KM, Trono D, Pittet D, Gétaz L, Chappuis F, Eckerle I, Vuilleumier N, Meyer B, Flahault A, Kaiser L, Guessous I. Stringhini S, et al. Among authors: kaiser l. Lancet. 2020 Aug 1;396(10247):313-319. doi: 10.1016/S0140-6736(20)31304-0. Epub 2020 Jun 11. Lancet. 2020. PMID: 32534626 Free PMC article.
Clinical features of covid-19.
Vetter P, Vu DL, L'Huillier AG, Schibler M, Kaiser L, Jacquerioz F. Vetter P, et al. Among authors: kaiser l. BMJ. 2020 Apr 17;369:m1470. doi: 10.1136/bmj.m1470. BMJ. 2020. PMID: 32303495 No abstract available.
Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism.
Cagno V, Andreozzi P, D'Alicarnasso M, Jacob Silva P, Mueller M, Galloux M, Le Goffic R, Jones ST, Vallino M, Hodek J, Weber J, Sen S, Janeček ER, Bekdemir A, Sanavio B, Martinelli C, Donalisio M, Rameix Welti MA, Eleouet JF, Han Y, Kaiser L, Vukovic L, Tapparel C, Král P, Krol S, Lembo D, Stellacci F. Cagno V, et al. Among authors: kaiser l. Nat Mater. 2018 Feb;17(2):195-203. doi: 10.1038/nmat5053. Epub 2017 Dec 18. Nat Mater. 2018. PMID: 29251725 Free article.
Validation of a commercially available SARS-CoV-2 serological immunoassay.
Meyer B, Torriani G, Yerly S, Mazza L, Calame A, Arm-Vernez I, Zimmer G, Agoritsas T, Stirnemann J, Spechbach H, Guessous I, Stringhini S, Pugin J, Roux-Lombard P, Fontao L, Siegrist CA, Eckerle I, Vuilleumier N, Kaiser L; Geneva Center for Emerging Viral Diseases. Meyer B, et al. Among authors: kaiser l. Clin Microbiol Infect. 2020 Oct;26(10):1386-1394. doi: 10.1016/j.cmi.2020.06.024. Epub 2020 Jun 27. Clin Microbiol Infect. 2020. PMID: 32603801 Free PMC article.
1,062 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page